Ubs Group Ag Eli Lilly & CO Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Eli Lilly & CO stock. As of the latest transaction made, Ubs Group Ag holds 186,194 shares of LLY stock, worth $149 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

186,194

Previous 2,962,821 93.72%

Holding current value

$149 Million

Previous $2.68 Billion 93.85%

% of portfolio

0.04%

Previous 0.67%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $489 Million - $608 Million	633,098 Added 21.37%	3,595,919 $3.19 Billion
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $198 Million - $249 Million	273,596 Added 10.17%	2,962,821 $2.68 Billion
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $86 Million - $115 Million	145,246 Added 5.71%	2,689,225 $2.09 Billion
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $169 Million - $199 Million	320,958 Added 14.44%	2,543,979 $1.48 Billion
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $94.5 Million - $130 Million	-217,432 Reduced 8.91%	2,223,021 $1.19 Billion
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $38.4 Million - $51.4 Million	109,536 Added 4.7%	2,440,453 $1.14 Billion
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $131 Million - $154 Million	423,025 Added 22.17%	2,330,917 $800 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $275 Million - $321 Million	855,819 Added 81.35%	1,907,892 $698 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $40 Million - $45.5 Million	-134,813 Reduced 11.36%	1,052,073 $340 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $9.51 Million - $11.2 Million	-34,135 Reduced 2.8%	1,186,886 $385 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $51.4 Million - $63.9 Million	-218,932 Reduced 15.2%	1,221,021 $350 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $3.58 Million - $4.44 Million	15,929 Added 1.12%	1,439,953 $398 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $19.5 Million - $24 Million	88,136 Added 6.6%	1,424,024 $329 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $37.2 Million - $48.1 Million	205,800 Added 18.21%	1,335,888 $307 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $43.9 Million - $56.9 Million	-267,360 Reduced 19.13%	1,130,088 $211 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $45 Million - $59.6 Million	345,099 Added 32.79%	1,397,448 $236 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $6.58 Million - $7.62 Million	-45,031 Reduced 4.1%	1,052,349 $156 Million
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $11.4 Million - $13.7 Million	-83,396 Reduced 7.06%	1,097,380 $180 Million
Q1 2020 May 01, 2020	SELL	$119.05 - $147.35 $49.9 Million - $61.7 Million	-418,822 Reduced 26.18%	1,180,776 $164 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $32.3 Million - $40 Million	301,855 Added 23.26%	1,599,598 $210 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $9.05 Million - $9.85 Million	84,767 Added 6.99%	1,297,743 $145 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $11.8 Million - $13.8 Million	-106,700 Reduced 8.09%	1,212,976 $134 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $17.1 Million - $20.2 Million	153,997 Added 13.21%	1,319,676 $171 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $14.4 Million - $16.1 Million	-135,676 Reduced 10.43%	1,165,679 $135 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $540,402 - $675,409	-6,294 Reduced 0.48%	1,301,355 $140 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $13.7 Million - $15.7 Million	-180,489 Reduced 12.13%	1,307,649 $112 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $2.36 Million - $2.78 Million	-31,772 Reduced 2.09%	1,488,138 $115 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $26.3 Million - $28.2 Million	320,444 Added 26.72%	1,519,910 $128 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $18.9 Million - $21 Million	-245,097 Reduced 16.97%	1,199,466 $103 Million
Q2 2017 Aug 14, 2017	BUY	N/A	175,275 Added 13.81%	1,444,563 $119 Million
Q1 2017 Nov 14, 2017	BUY	N/A	1,269,288	1,269,288 $107 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account